Type 2 Diabetes in Pregnancy: Management and Novel Therapies

View at publisher Summarise with VIRAT
Authors: Gianna Wilkie
Cited by: 0
References: 35

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Type 2 diabetes mellitus (T2DM) is estimated to affect 2% of all pregnancies, and it is associated with numerous adverse perinatal outcomes. Glycemic monitoring and strict glycemic control are required to improve overall outcomes. Insulin is the mainstay of treatment, with limited data regarding newer medications like glucagon-like peptide 1 receptors agonists (GLP-1 RAs), dual incretin agonists like tirzepatide, sodium-glucose cotransporter-2 inhibitors (SGLT2i), and dipeptidyl peptidase-4 inhibitors (DPP-4i). This chapter will provide a review of the current available literature regarding T2DM management in pregnancy.

Fields of Study & Subjects

Gestational Diabetes Research and Management Pregnancy and Medication Impact Diabetes Treatment and Management

Publication details

Journal / source
Clinical Obstetrics & Gynecology
Volume
69
Issue
2
Pages
203–209
Publication date
25 March 2026
Language
EN